Futura Medical Share Discussion Threads

[petroc] 23/7/2023 12:50

Swap out the word rampers and LiarBOoth is talking about himself, or should I say himselves?

'Yet again another proven attempt at ‘bias and fraud’ by a group of connected multi-ID stock bashers (rampers) who have incentivised to post ‘fraud’ by ‘fantastic financial incentives’ and pumping the placebo gel ‘form of fraud’



Bias and Fraud

There are numerous biases in medical research that render evidence from such research systematically misleading. Some of these biases are exacerbated by conflicts of interest, including fantastic financial incentives. The most important biases in medical research include confirmation bias, design bias, analysis bias, and publication bias. Arguably, some forms of bias, such as publication bias, should be considered as fraud

[joestalin] 23/7/2023 10:48

How would he know? He spends all his life at the computer screen.

[beanol] 22/7/2023 15:54

LBO1Thanks for this and your previous associated post. There are some helpful cautionary points in both. Couple of points I'm not a ramper. I came across this share early year and invested £5k, sold at a loss. Then invested again a larger amount. I am £3k up. I use this BB to see updated news and do my own research. And of course I like sharing views and challenging/confirming my own views and hypotheses. I wouldn't see this as being controversial. I have (some) relevant professional experience at a senior level and a few relevant contacts in the industry (although none with direct access). Your point about the history of FUM and deals that have not fulfilled their potential are difficult to argue against. If that's what happened I can understand that anybody who's experienced this would want to warn other investors. On the De Novo issue yes ...BUT the 3 shares I have invested in which achieved this status including GWP Pharma all went on to do really well. It IS an indication of FDA recognition of certain criteria. In terms of Haleon, I spoke to the wife of a close friend who works for them yesterday in a not commercial area. . She didn't say anything confidential but did say that the deal had generated a bit of a buzz inside the company and much mirth. In one of the internal comments the company confirmed that it had verified the product as being safe to use but would not be giving out free samples....I will be holding for the duration now ie until as you predict the product fails or in the unlikely event it succeeds. It remains odd to me that the share price has not improved substantially given such stonking good recent news.

[keifer derrin] 22/7/2023 11:38

Broomrigg - thanks for the NAO links. Although I have been in contact with them as they information is out of date and in a few places actually wrong.

[thebutler] 22/7/2023 10:58

*AMAZON REVIEWS UPDATE*

Latest 2 reviews:

"Bought for my partner. Didn't work in the slightest. Ended up using all 4 tubes of gel and still no results. An absolute waste of money. Do not recommend in the slightest. My recommendation is to stick to Viagra; it costs less and actually works!"

"Did not work for me.
Reading the ingredients I might give my a drink of whisky/gin/vodka instead.
(Ethanol is the largest ingredient)."

LOL!

[broomrigg] 22/7/2023 09:57

From LSE......


US sales imminent.......







:- )

[broomrigg] 22/7/2023 09:56

Thanks for posting re. Investor's Chronicle beanol......brilliant

[beanol] 22/7/2023 09:39

FUM mentioned as first buy recommendation in yesterday's Investors Chronicle. LBO and co - if FUM gets its patent extension (which presumably Haleon have taken a view on?) do your objections fall away? Simple question?

[thebutler] 22/7/2023 08:40

Monthly sales of eroxon now down to 4k on Amazon. The sales are becoming somewhat floppy, LOL!